OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Gedeon Richter Ltd/  HU0000123096  /

Nasdaq Other OTC
4/29/2024  8:48:49 PM Chg. +0.4200 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
28.1900USD +1.51% 1
Turnover: 28.1900		 -Bid Size: - -Ask Size: - 5 bill.USD - -
GlobeNewswire 5/3 Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the c...
GlobeNewswire 3/25 Gedeon Richter Selects Trial Interactive for Clinical Trial Management
GlobeNewswire 9/11/2023 Letter to Shareholders and Corporate Update
GlobeNewswire 1/26/2022 Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Upd...
GlobeNewswire 1/10/2022 Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021
GlobeNewswire 10/26/2021 Myovant Sciences Announces Financial Results for Second Quarter of Fiscal Year 2021 and Corporate Up...
GlobeNewswire 7/28/2021 Myovant Sciences Announces Financial Results for First Quarter of Fiscal Year 2021 and Corporate Upd...
GlobeNewswire 7/20/2021 Myovant Sciences Announces European Commission Approval for RYEQO® for the Treatment of Women With U...
GlobeNewswire 5/21/2021 Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Tr...
GlobeNewswire 5/11/2021 Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fis...
GlobeNewswire 2/11/2021 Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal Year ...
GlobeNewswire 11/12/2020 Myovant Sciences Announces Corporate Updates and Financial Results for Second Quarter Fiscal Year 20...
GlobeNewswire 8/11/2020 Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 202...
GlobeNewswire 5/18/2020 Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for Fourth Fiscal Q...
GlobeNewswire 3/31/2020 Myovant Sciences and Gedeon Richter Enter into Exclusive License Agreement to Commercialize Relugoli...
GlobeNewswire 7/5/2019 Global Osteoporosis Market & Drug Outlook 2017-2027: Current Market Leader Prolia Will Make Way for ...
GlobeNewswire 6/13/2019 Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update
GlobeNewswire 3/5/2019 Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Yea...
GlobeNewswire 3/1/2019 Mithra Reports 2018 Annual Results
GlobeNewswire 2/5/2019 Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other ...
GlobeNewswire 1/23/2019 Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 3...
GlobeNewswire 1/11/2019 Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including...
GlobeNewswire 1/2/2019 Easton Pharmaceuticals Announces Signing and Commencement of $2,600,000 Framing Contract to Construc...
GlobeNewswire 12/18/2018 Easton Pharmaceuticals Completes Purchase of Development Project with Total Projected Profit in Exce...
GlobeNewswire 12/12/2018 Easton Pharmaceuticals Provides Company Update Including Hotel Acquisition in Toronto, BAYER Agreeme...